14 results
Direct-acting oral anticoagulants (DOACs) for VTE treatment and prevention - Comparison Table

#DOAC #Anticoagulants #Anticoagulation #VTE #Management
Direct-acting oral ... treatment and prevention ... - Comparison Table ... VTE #Management #Pharmacology ... #Comparison #Table
Transdermal Fentanyl require unique dosing conversions. For Adult and pediatric patients taking opiouds or doses not
require unique dosing ... conversions. ... the equinalgesic oral ... #Pharmacology #Pain ... Opiate #Opioid #Conversion
Comparison of oral anticoagulant agents (DOACS + Warfarin)

Reference: ENLS 2017 Pharmacotherapy. Neurocritical Care Journal.

#DOAC #Dosing #Oral
Comparison of oral ... #DOAC #Dosing #Oral ... Anticoagulation #Comparison ... #Table #Pharmacology
Bisphosphonates for Osteoporosis Treatment or Prevention 

Bisphosphonates are common medications used in the treatment and prevention
Osteoporosis Treatment or Prevention ... treatment and prevention ... are a variety of dosing ... is to take the oral ... Schedule #Frequency #Pharmacology
Antiplatelet Conversion - Switching Between P2Y12 Inhibitors
Oral P2Y12 inhibitors vary in potency and pharmacokinetic and dynamic
Antiplatelet Conversion ... P2Y12 Inhibitors Oral ... Cangrelor) and Oral ... Switching Among Oral ... ticagrelor #prasugrel #pharmacology
Intern Pocket Cards - Pharmacologic Pain Management Options
Anti-inflammatory:
 • Acetaminophen (24 hours: < 3-4g in healthy
Pocket Cards - Pharmacologic ... cirrhosis) • Oral ... Equianalgesia Conversion ... #Pain #Opioid #Conversion ... internship #guide #comparison
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
• Itraconazole oral ... • Posaconazole oral ... • Itraconazole oral ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Switching Between Oral ... Switching between oral ... the timing and dosing ... Switching between oral ... ticagrelor #prasugrel #pharmacology
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... five effective oral ... If needed or if oral ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
IDSA Recommendations ... for Preventing ... specialist) + ART • Oral ... KaposiSarcoma #Castlemans #IDSA ... infections #HIVAIDS #pharmacology